- Article
Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial
- Peter Oppelt,
- Jessica Ley,
- Christine Auberle,
- Brendan Knapp,
- Jesse Zaretsky,
- Fei Wan and
- Douglas Adkins
Background/Objectives: Functional p53 is critical for anti-tumor activity of mitomycin-C. In wild-type TP53 human papillomavirus (HPV)-positive squamous cell carcinoma (SCC) cell lines, mitomycin-C repressed E6 oncoprotein expression and induced p53,...